We need to lower the price of insulin and help millions of working families.

Here’s where we are. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Lisa Blunt Rochester for Congress

Far too many Americans with diabetes face an impossible choice: pay for their insulin, or pay for other basic living essentials.

LBR believes that no one should be forced into a situation like that, and she's taken action to do something about it.

Will you join LBR and sign your name to support legislation that lowers the cost of insulin?

Add Your Name

A few weeks ago, LBR proudly voted with her Democratic House colleagues to cap the price of insulin at $35 — making it more affordable for millions of working families.

NBC News: House passes bill to cap out-of-pocket insulin costs

We need to do everything we can to power this legislation through the Senate and to President Biden's desk.

No one should have to pay a fortune to afford life-saving medication, and the drug companies currently taking advantage of Americans need to be reigned in. This bill is a key part of how we do that.

So please, add your name to our petition. We need 5,000 signatures in order to amplify our call to action →

Add Your Name

Thanks,

Team LBR

 

Congresswoman Lisa Blunt Rochester is a Democrat representing the First State, Delaware. She served as the National Co-Chair of the Biden-Harris campaign and Co-Chair of the DCCC ‘Red to Blue’ program. Lisa is running for reelection to continue fighting for our health care, leading the charge toward environmental justice, and advocating for working families like hers.

DONATE
 
 
 
 
 
Paid for by Lisa Blunt Rochester for Congress

Lisa Blunt Rochester for Congress
PO BOX 9767
Wilmington, DE 19810
United States